Philips CPAP Recall Lawsuits in 2026: Foam Degradation Claims Update
In 2026, the Philips CPAP litigation has entered its payment phase for most claimants. Philips agreed to a $1.075 billion personal injury settlement that began paying claimants in early 2026, alongside a $479 million economic loss settlement, while a smaller group of non-settling cases heads toward trial. Here is the status, who remains eligible, and what device owners should know.
Key Facts
- Philips Respironics announced a $1.075 billion personal injury settlement in April 2024 over recalled CPAP, BiPAP, and ventilator devices. Philips fully funded it in March 2025, and payments to eligible claimants began in early 2026. Source: Cellino Law, October 2026.
- A separate $479 million settlement resolved the economic loss class action. Source: Cellino Law, October 2026.
- The June 2021 recall covered about 5.5 million devices in the United States and 15 million globally. Source: Legal Examiner, 2026; Reuters, October 10, 2026.
- The FDA has received more than 116,000 adverse event reports related to the recalled devices, including 561 reports of death linked to foam degradation. Source: MassTortInfo, 2026.
- About 619 active cases remained in the federal MDL (MDL 3014, W.D. Pennsylvania, Judge Joy Flowers Conti) as of March 2026, with claims still being processed in September 2026. Source: MassTortInfo; Schmidt and Clark, October 2026.
The Foam Problem Behind the Recall
The defect was a sound-dampening material: polyester-based polyurethane foam, known as PE-PUR, installed inside millions of Philips sleep and respiratory devices to reduce machine noise. Philips discovered the foam could break down over time, releasing tiny particles and chemicals into the device's air pathway for users to inhale or swallow.
Heat, humidity, and ozone cleaning were believed to accelerate the degradation. Lawsuits alleged Philips knew about the foam problem years before the June 2021 recall. In April 2024, a federal consent decree restricted Philips Respironics from manufacturing and selling new devices until remediation requirements were met. Families dealing with device-related harm can learn how such claims are investigated from our guide to medical device and procedure injury claims.
The Settlement Landscape in 2026
The personal injury settlement, announced at $1.075 billion in April 2024, resolved claims that foam exposure caused cancer, respiratory illness, and other serious conditions. Philips fully funded the program in March 2025, and payments began in early 2026 under a points-based allocation weighting diagnosis, device usage, and medical documentation.
The $479 million economic loss settlement covered people who bought or rented recalled devices and suffered financial harm, including replacement machine costs and loss of use. Registration and participation deadlines for both programs have now passed, which is why most law firms describe the Philips docket as substantially resolved for new claimants. Compensation varies widely by case, and most individual allocations are confidential.
Who Is Still Eligible for Compensation
For people already registered, eligibility is a matter of claims processing: the court and the administrator continued entering orders on registered claims through September 2026.
For people who never registered, the door is nearly closed but not entirely shut: some individual cancer cases may still be viable outside the program. About 619 cases remained active in the MDL, and in September 2026 the court appointed lead counsel for the smaller group of litigating plaintiffs pursuing individual cases, with bellwether trials projected for late 2026. Anyone in this position needs an experienced medical device attorney immediately and should preserve the device, purchase records, and medical documentation. Similar narrow exceptions for late-discovered injuries exist in other settlement programs, as seen in the Camp Lejeune claims process.
Device Safety After the Recall
Patients who still own an affected device should ask their equipment provider or physician about replacement or repair options. Manufacturers discourage ozone cleaners on any CPAP device, since ozone degrades internal materials.
Anyone with new respiratory symptoms while using a recalled device should seek medical evaluation and mention the device history. Documenting the serial number, usage period, and any symptoms creates a record that matters both medically and legally. For ongoing context on device recalls, watch explainer videos on Problem Solved on YouTube.
Who Benefits From This — and Who Does Not
Registered settlement claimants. People already in the programs benefit from knowing the payment timeline: the $1.075 billion fund was fully funded in March 2025 and payments began in early 2026.
People diagnosed with cancer or serious respiratory illness after using a recalled device. Even though program deadlines passed, some individual cases remain viable outside the settlement, and an experienced attorney can assess the facts. See how mass tort cases proceed after major settlements for claims that did not settle.
Current CPAP users worried about device safety. Understanding the foam defect, the ozone warning, and remediation options helps any sleep apnea patient use their machine more safely.
People who never used a recalled Philips device do not benefit. The recall covered specific Philips Respironics models made before April 2021; users of other brands or non-recalled Philips devices have no claim here.
People who used a device but suffered no health effects do not benefit from the injury settlement. The personal injury program required a qualifying injury with medical documentation, and economic loss deadlines have also passed.
Anyone expecting to join the settlement programs now does not benefit. Registration deadlines have passed; the remaining cases are individual litigating plaintiffs, not new settlement entrants.
This article provides general information only and is not legal advice. Laws and procedures vary by state and change over time; consult a qualified attorney about your situation.
Frequently Asked Questions
Who benefits from the Philips CPAP settlement information in 2026
Registered claimants benefit, because payments began in early 2026 and claims processing continues. People with a qualifying injury who never registered may also benefit from a legal review.
Who is not eligible for the Philips CPAP personal injury settlement
People who never registered during the enrollment period are not eligible, as are people who used devices not on the recall list or who lack a qualifying documented injury.
How do I start a Philips CPAP claim if I used a recalled device
First, confirm your device is on the recall list using the model and serial number. Second, gather proof of purchase or rental, usage dates, and complete medical records. for any condition you link to the device. Third, contact an experienced medical device attorney immediately. Fourth, do not discard the device, since it may be evidence.
When did Philips CPAP settlement payments begin
Philips fully funded the $1.075 billion settlement in March 2025, and payments began in early 2026 through the claims administrator.
Is it safe to keep using a recalled Philips device today
You should not continue using a recalled device without guidance. Contact your equipment provider or physician about current remediation options, avoid ozone cleaners on any CPAP device, and report respiratory symptoms to your doctor.